EPTIS
BAM Logo

Immunophenotyping

EPTIS factsheet 790739 | Last revision 2020-10-23 | URL: https://www.eptis.bam.de/pts790739 https://www.eptis.bam.de/pts790739

PT provider
PT provider RCPAQAP RCPAQAP
Based in Australia
Language(s) English
Remarks The material assayed is fresh whole blood, which quickly deteriorates under normal transport conditions and should be tested within 3-4 days of dispatch. As such this program is only available to a limited number of destinations outside Australia, New Zealand, Malaysia, Singapore and Hong Kong. Please contact Customer Service at customer.service@rcpaqap.com.au if you are outside these areas.
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
EDTA whole blood with commercial cell stabiliser Lymphocytes (%) CD3+
CD3+CD4+
CD3+CD8+
CD19+
CD3-CD16+
CD3-CD56+
CD3-CD16+CD56+
Alpha-Beta Double negative or double positive lymphocyte percentages
Lymphocytes (absolute numbers) CD3+
CD3+CD4+
CD3+CD8+
CD19+
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee
Regularly operated Yes (2 samples per survey/8 surveys)
Year of first operation
Contact details of the PT provider
Provider Contact person
RCPAQAP
Suite 201/8 Herbert Street
St Leonards, 2065
Australia

Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Web: https://www.rcpaqap.com.au/ https://www.rcpaqap.com.au/
Mr Rhys Judd
Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Email: rhys.judd@rcpaqap.com.au rhys.judd@rcpaqap.com.au
If you find any mistakes please contact the responsible EPTIS coordinator in Australia, Ms Luminita Antin. Ms Luminita Antin.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5